Romania's Farmexim looking to expand

10 July 2001

The Farmexim Bucharest pharmaceuticals importer and distributor inRomania has said it plans to expand its drugstore network nationwide this year, according to the Mediafax news agency. The company currently operates 11 HelpNet drug stores, of which 10 are in Bucharest and one in Timisoara. New stores are planned in Brasov, Constanta and Cluj, though it was noted that Farmexim's investment plan is contingent upon favorable economic developments in Romania.

However, according to Farmexim, the main problems facing pharmaceutical importers and distributors in Romania are an unstable business environment and insufficient funding of the health care system. It is calling for a reduction in value-added tax on medicines and increased health spending. Farmexim, established in 1990, recorded turnover of $10 million in the first five months of this year, and expects full-year 2001 revenues to reach $24.5 million.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight